Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-25

FDA Approved: PEMETREXED — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved BluePoint Laboratories' Original Application for a generic pemetrexed product (PEMETREXED), authorizing its manufacture and sale under an ANDA. Pem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemetrexed (pemetrexed)

Snippet

ORIG AP for PEMETREXED (PEMETREXED)